Skip to Main Content

Paper Details

The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients.
Pharmacogenet Genomics
76
2012
ADME) gene variants, CYP3A4 variants, CYP3A5, CYP3A5 rs776746, DNA biobank, DNA biobanks, NR1I2 variants, Tacrolimus, hemoglobin, polymorphisms, rs776746, tacrolimus
Author NameAffiliation
Kelly A BirdwellVanderbilt University Medical Center
  • 1 - 1

Datasets

Release 1.2